Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Cahn

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Plos One|June 16, 2017
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassayClaudia Frola, Liliana Guelfand, Gabriela Blugerman, et al.
Trials|November 26, 2010
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialDarrell H S Tan, Janet M Raboud, Rupert Kaul, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2004
Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from ArgentinaSilvia Sánchez Puch, Claudia Ochoa, Guadalupe Carballal, et al.
AIDS (London, England)|November 5, 2008
Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsAndrew Carr, Armin Ritzhaupt, Wei Zhang, et al.
International Journal for Equity in Health|September 28, 2014
Factors associated with healthcare avoidance among transgender women in ArgentinaMaría Eugenia Socías, Brandon D L Marshall, Inés Arístegui, et al.
Journal of Virology|January 11, 2008
Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variantsGabriela Turk, María Magdalena Gherardi, Natalia Laufer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infectionCarlos Zala, Horacio Salomon, Claudia Ochoa, et al.
Plos One|January 12, 2013
Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelDario A Dilernia, Daniela C Monaco, Carina Cesar, et al.
Plos One|February 6, 2016
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsJean-Guy Baril, Jonathan B Angel, M John Gill, et al.
Antiviral Therapy|April 9, 2008
Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimenHéctor Pérez, Moira Vignoles, Natalia Laufer, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Plos One|June 16, 2017
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassayClaudia Frola, Liliana Guelfand, Gabriela Blugerman, et al.
Trials|November 26, 2010
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialDarrell H S Tan, Janet M Raboud, Rupert Kaul, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2004
Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from ArgentinaSilvia Sánchez Puch, Claudia Ochoa, Guadalupe Carballal, et al.
AIDS (London, England)|November 5, 2008
Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsAndrew Carr, Armin Ritzhaupt, Wei Zhang, et al.
International Journal for Equity in Health|September 28, 2014
Factors associated with healthcare avoidance among transgender women in ArgentinaMaría Eugenia Socías, Brandon D L Marshall, Inés Arístegui, et al.
Journal of Virology|January 11, 2008
Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variantsGabriela Turk, María Magdalena Gherardi, Natalia Laufer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2002
Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infectionCarlos Zala, Horacio Salomon, Claudia Ochoa, et al.
Plos One|January 12, 2013
Estimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelDario A Dilernia, Daniela C Monaco, Carina Cesar, et al.
Plos One|February 6, 2016
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed PatientsJean-Guy Baril, Jonathan B Angel, M John Gill, et al.
Antiviral Therapy|April 9, 2008
Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimenHéctor Pérez, Moira Vignoles, Natalia Laufer, et al.
Pageof 21